bibliographicCitation |
Wu YZ, Wu M, Zheng XH, Wang BZ, Xue LY, Ding SK, Yang L, Ren JS, Tian YT, Xie YB. No long-term survival benefit with sustained-release 5-fluorouracil implants in patients with stages II and III gastric cancer. World J Gastroenterol. 2022 Oct 14;28(38):5589–601. PMID: 36304092; PMCID: PMC9594009. |